Cardiovascular risk associated with the metabolic syndrome (Q35649432)

9 August 2017

1 reference

title

Cardiovascular risk associated with the metabolic syndrome (English)

1 reference

9 August 2017

1 reference

1 reference

Robert S Lindsay

1

1 reference

PubMed ID

14764282

9 August 2017

Barbara V Howard

series ordinal

2

1 reference

PubMed ID

14764282

9 August 2017

language of work or name

1 reference

1 February 2004

1 reference

9 August 2017

Current diabetes report

1 reference

9 August 2017

4

1 reference

9 August 2017

1

1 reference

9 August 2017

63-68

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-004-0013-9

9 August 2017

0 references

cites work

Development of the multiple metabolic syndrome: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0013-9

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0013-9

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0013-9

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0013-9

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-004-0013-9

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

12 December 2020

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

1 reference

12 December 2020

Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.

1 reference

12 December 2020

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

12 December 2020

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease

1 reference

12 December 2020

Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

12 December 2020

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

12 December 2020

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

12 December 2020

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

1 reference

12 December 2020

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

1 reference

12 December 2020

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

1 reference

12 December 2020

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

12 December 2020

Critical periods in childhood for the development of obesity

1 reference

12 December 2020

Rising tide of cardiovascular disease in American Indians. The Strong Heart Study

1 reference

12 December 2020

The hormone resistin links obesity to diabetes

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

12 December 2020

Adiponectin and development of type 2 diabetes in the Pima Indian population

1 reference

12 December 2020

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

The fetal and infant origins of adult disease

1 reference

12 December 2020

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

12 December 2020

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

1 reference

12 December 2020

AdipoQ is a novel adipose-specific gene dysregulated in obesity

1 reference

12 December 2020

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

1 reference

12 December 2020

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

1 reference

12 December 2020

Tissue-specific dysregulation of cortisol metabolism in human obesity

1 reference

12 December 2020

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

12 December 2020

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

1 reference

12 December 2020

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

1 reference

12 December 2020

10.1007/S11892-004-0013-9

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14764282